Neurotrophic role of interleukin-6 and soluble interleukin-6 receptors in N1E-115 neuroblastoma cells

Journal of Neuroimmunology

Volumn 102, Issue 1, 2000, Pages 8-16

  Knezevic Cuca, Jadranka ^a   Stansberry, Kevin B ^a   Johnston, Gregory ^a   Zhang, Jian ^a,b   Keller, Evan T ^a,b   Vinik, Aaron I ^a   Pittenger, Gary L ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

IL 6; IL 6 Receptor; In vitro; Neuroblastoma; Neuropathy; Neurotrophic

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; IN VITRO STUDY; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES; BLOOD; BLOOD PHYSIOLOGY; CATTLE; CELL DIVISION; CULTURE MEDIA, SERUM-FREE; DOSE-RESPONSE RELATIONSHIP, DRUG; FETAL BLOOD; INTERLEUKIN-6; MICE; NERVE GROWTH FACTORS; NEUROBLASTOMA; OSMOLAR CONCENTRATION; RECEPTORS, INTERLEUKIN-6; SOLUBILITY; TUMOR CELLS, CULTURED;

EID: 0033992219     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00151-4     Document Type: Article

References (36)

1. Barroso M.P., Gomez-Diaz C., Villalba J.M., Buron M.I., Lopez-Lluch G., Navas P. Plasma membrane ubiquinone controls ceramide production and prevents cell death induced by serum withdrawal. J. Bioenerg. Biomembr. 29:1997;259-267.
2. Bartfai T., Schultzberg M. Cytokines in neuronal cell types. Neurochemistry. 22:1993;435-444.
3. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
4. Creange A., Barlovatz-Meimon G., Gherardi R.K. Cytokines and peripheral nerve disorders. Eur. Cytokine Network. 8:1997;145-151.
5. Gaillard J.P., Bataille R., Brailly H., Zuber C., Yasukawa K., Attal M., Maruo N., Taga T., Kishimoto T., Klein B. Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. Eur. J. Immunol. 23:1993;820-824.
6. Hirano T. Interleukin 6 and its receptor: ten years later. Int. Rev. Immunol. 16:1998;249-284.
7. Hirota H., Kiyama H., Kishimoto T., Taga T. Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma. J. Exp. Med. 183:1996;2627-2634.
8. Howard M.K., Burke L.C., Mailhos C., Pizzey A., Gilbert C.S., Lawson W.D., Collins M.K., Thomas N.S., Latchman D.S. Cell cycle arrest of proliferating neuronal cells by serum deprivation can result in either apoptosis or differentiation. J. Neurochem. 60:1993;1783-1791.
9. Hull M., Strauss S., Berger M., Volk B., Bauer J. The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behav. Brain Res. 78:1996;37-41.
10. Ikeda K., Kinoshita M., Tagaya N., Shiojima T., Taga T., Yasukawa K., Suzuki H., Okano A. Co-administration of IL-6 and soluble IL-6 receptor delays progression of Wobbler mouse motor neuron disease. Brain Res. 726:1996;91-97.
11. Jarskog L.F., Xiao H., Wilkie M.B., Lander J.M., Gilmore J.H. Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro. Int. J. Dev. Neurosci. 15:1997;711-716.
12. Karkar A.M., Smith J., Tam F.W., Pusey C.D., Rees A.J. Abrogation of glomerular injury in nephrotoxic nephritis by continuous infusion of interleukin-6. Kidney Int. 52:1997;1313-1320.
13. Keller E.S., Wanagat J., Ershler W.B. Molecular and cellular biology of interleukin-6 and its receptor. Front. Biosci. 1:1996;D340-D357.
14. Kushima Y., Hatanaka H. Culture of neuronal cells from postnatal rat brain: application to the study of neurotrophic factors. J. Neuropsychopharmacol. Biol. Psychiatry. 16:1992;617-633.
15. Lin S., Yamate T., Tguchi Y., Borba V., Girasole G., O'Brien C.A., Bellido T., Abe E.M.S. Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow. J. Clin. Invest. 100:1997;1980-1990.
16. Loddick S.A., Turnbull A.V., Rothwell N.J. Cerebral IL-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 18:1998;176-179.
17. Maeda Y., Matsumoto M., Hori O., Kuwabara K., Ogawa S., Yan S.D., Ohtsuki T., Kinoshita T., Kamada T., Stern D.M. Hypoxia/reoxygenation-mediated induction of astrocyte interleukin-6: a paracrine mechanism potentially enhancing neuronal survival. J. Exp. Med. 180:1994;2297-2308.
18. Maimone D., Annunziata P., Simone I.L., Livrea P., Guazzi G.C. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barrè syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J. Neuroimmunol. 47:1993;55-61.
19. Marz P., Herget T., Lang E., Otten U., Rose-John S. Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation. Eur. J. Neurosci. 9:1997;2765-2773.
20. Marz P., Cheng J.G., Gadient R.A., Pattersen P.H., Stoyan T., Otten U., Rose-John S. Sympathetic neurons can produce and respond to interleukin 6. Proc. Natl. Acad. Sci. U.S.A. 95:1998;3251-3256.
21. Moroni S.C., Rossi A. Enhanced survival and differentiation in vitro of different neuronal populations by some interleukins. Int. J. Dev. Neurosci. 13:1995;41-49.
22. Pittenger G.L., Liu D., Vinik A.I. The toxic effects of serum from patients with type I diabetes mellitus on mouse neuroblastoma cells: a new mechanism for development of autonomic neuropathy. Diabetic Med. 10:1993;925-932.
23. Pittenger G.L., Liu D., Vinik A.I. The neuronal toxic factor in serum of type 1 diabetic patients is a complement-fixing autoantibody. Diabetic Med. 12:1995;380-386.
24. Pittenger G.L., Liu D., Vinik A.I. The apoptotic death of neuroblastoma cells caused by serum from patients with insulin-dependent diabetes and neuropathy may be Fas-mediated. J. Neuroimmunol. 76:1997;153-160.
25. Reichert F., Levitzky R., Rotshenker S. Interleukin 6 in intact and injured mouse peripheral nerves. Eur. J. Neurosci. 8:1996;530-535.
26. Rose C., Zandecki M., Copin M.C., Gosset P., Labalette M., Hatron P.Y., Jaubertau M.O., Devulder B., Bauters F., Facon T. POEMS SYNDROME: report on six patients with unusual clinical signs, elevated levels of cytokines, macrophage involvement and chromosomal aberrations of bone marrow plasma cells. Leukemia. 11:1997;1318-1323.
27. Satoh T., Nakamura S., Tage T., Matsuda T., Hirano T., Kishimoto T., Kaziro Y. Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6. Mol. Cell. Biol. 8:1988;3546-3549.
28. Shimada K., Koh C.S., Yanagisawa N. Detection of interleukin-6 in serum and cerebrospinal fluid of patients with neuroimmunological diseases. Arerurgi. 42:1993;934-940.
29. Takizawa H., Ohtoshi T., Yamashita N., Oka T., Ito K. Interleukin 6-receptor expression on human bronchial epithelial cells: regulation by IL-1 and IL-6. Am. J. Physiol. 270:1996;L346-L352.
30. Taylor S.C., Shacks S.J., Mitchell R.A., Banks A. Serum interleukin-6 levels in the steady state of sickle cell disease. Interferon Cytokine Res. 15:1995;1061-1064.
31. Teague T.K., Marrack P., Kappler J.W., Vella A.T. IL-6 rescues resting mouse T cells from apoptosis. J. Immunol. 158:1997;5791-5796.
32. Toulmond S., Vige X., Fage D., Benavides J. Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci. Lett. 144:1992;49-52.
33. Umegaki H., Yamada K., Naito M., Kameyama T., Iguchi A., Nabeshima T. Protective effect of interleukin-6 against the death of PC 12 cells caused by serum deprivation or by the addition of calcium ionophore. Biochem. Pharmacol. 52:1996;911-916.
34. Wagner J.A. Is IL-6 both a cytokine and a neurotrophic factor? J. Exp. Med. 183:1996;2417-2419.
35. Xing Z., Gauldie J., Cox G., Baumann H., Jordana M., Lei X.F., Achong M.K. IL-6 is an anti-inflammatory cytokine required for controlling local or acute inflammatory responses. J. Clin. Invest. 101:1998;311-320.
36. Yamazaki K., Yamada E., Kanaji Y., Shizume K., Wang D.S., Maruo N., Obara T., Sato K. Interleukin-6 (IL-6) inhibits thyroid function in the presence of soluble IL-6 receptor in cultured human thyroid follicles. Endocrinology. 137:1996;4857-4863.